comparemela.com

Latest Breaking News On - Consumer health segment - Page 2 : comparemela.com

Catalent, Inc Reports Second Quarter Fiscal 2024 Results

Q2 24 net revenue of $1.03 billion decreased 10% as reported, or 11% in constant currency, compared to Q2 23. Q2 24 net revenue, excluding COVID-related revenue of ~$260 million in Q2’23 and.

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Catalent (CTLT) Reports Prelim Q3 Revenue of $982M, EPS of ($0 10), Reaffirms FY24 Guidance

Catalent (CTLT) Reports Prelim Q3 Revenue of $982M, EPS of ($0 10), Reaffirms FY24 Guidance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Aytu BioPharma, Inc : Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Aytu BioPharma, Inc : Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.